Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

POMT1 – Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2K

In a six-generation consanguineous Han Chinese family, exome and Sanger sequencing identified compound heterozygous POMT1 variants c.1338+1G>A (p.His415LysfsTer3) and c.1457G>C (p.Trp486Ser) co-segregating with a later-onset limb-girdle muscular dystrophy phenotype (LGMD2K) characterised by progressive proximal pelvic and shoulder girdle weakness, joint contractures, intellectual disability, and elevated creatine kinase without structural brain or ocular defects (PMID:28157257). Segregation of both variants in two affected siblings supports autosomal recessive inheritance of LGMD2K.

Functional studies of POMT1 in Walker–Warburg syndrome demonstrate that patient-derived POMT1 truncating mutations abolish protein O-mannosyltransferase activity when co-expressed with POMT2 in Sf9 cells, indicating that loss of POMT1 enzymatic function underlies α-dystroglycan hypoglycosylation and muscle pathology (PMID:15522202).

References

  • Journal of Cellular and Molecular Medicine • 2017 • Compound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy-dystroglycanopathy C1. PMID:28157257
  • Biochemical and Biophysical Research Communications • 2004 • Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation. PMID:15522202

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Compound heterozygous POMT1 variants in a single family with AR LGMD2K; no additional unrelated cases

Genetic Evidence

Limited

2 affected siblings with co-segregating variants in one pedigree [PMID:28157257]

Functional Evidence

Moderate

POMT1 truncating mutations abolish enzymatic activity in heterologous expression assays [PMID:15522202]